Other languages Artivion, Inc.

Equities

AORT

US2289031005

Market Closed - Nyse Other stock markets 04:00:02 2024-06-10 pm EDT			5-day change	1st Jan Change
23.27 ^USD	-0.30%		-1.10%	+30.15%

May. 07	Stifel Adjusts Price Target on Artivion to $25 From $22, Maintains Buy Rating	MT
May. 07	Needham Adjusts Price Target on Artivion to $30 From $25, Maintains Buy Rating	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Artivion, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 06
Artivion, Inc. Revises Earnings Guidance for the Year 2024	May. 06
Artivion Files Mixed Shelf	Mar. 01
Artivion Insider Sold Shares Worth $1,358,818, According to a Recent SEC Filing	Feb. 22
Artivion, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 15
Artivion, Inc. Provides Earnings Guidance for the Year 2024	Feb. 15
Artivion Enters $350 Million Credit Facilities	Jan. 18
Artivion Insider Sold Shares Worth $273,543, According to a Recent SEC Filing	Dec. 19
Artivion Completes Enrollment in Clinical Trial of Aortic Arch Remodeling Device	Nov. 09
Artivion, Inc. Announces Completion of Enrollment in PERSEVERE Trial	Nov. 09
Artivion, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 02
Artivion, Inc. Revises Earnings Guidance for the Year 2023	Nov. 02
Artivion, Inc. Announces Data from On-X Aortic Heart Valve Low INR Post-Market Study Presented in A Late-Breaking Science Session At the 37European Association for Cardio-Thoracic Surgery Annual Meeting	23-10-05
Artivion, Inc. Revises Earnings Guidance for the Full Year 2023	23-08-03
Artivion, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-03
Insider Sell: Artivion	23-06-08
Sector Update: Health Care Stocks Dropping Late Afternoon	23-05-23
Sector Update: Health Care Stocks Declining Tuesday Afternoon	23-05-23
Artivion Receives FDA Premarket Application Approval for PerClot Bleeding Control System	23-05-23
Artivion Announces FDA PMA Approval of PerClot and Transfer of PMA to Baxter	23-05-23

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Artivion, Inc.

Equities

AORT

US2289031005

Other languages

Filters